Clinical Trials Search
Phase II Trial: Evaluation of the Role of Multiple Metastasectomy Combined with Systemic and Hepatic Artery Infusion Chemotherapy for Colorectal Carcinoma Metastatic to the Liver
92-46-52
- Eligibility:Click Here to View1.0) Ability to withstand operative procedure.
2.0) Patients may have received prior adjuvant 5FU with or without levamisole and/or leucovorin.
Drugs: Floxuridine, 5-FU, Leucovorin - Consent forms:You must be logged in to view the documents.
- Protocols:You must be logged in to view the documents.
A Phase I/II Dose Escalation Study using Thre Dimensional Conformal Radiation Therapy in Patients with Inoperable, Non-Small Cell Lung Cancer
93-11
- Eligibility:Click Here to View1.0) Stage I-IIIB (unresected).
2.0) PS >70
3.0) No malignant pleural effusion, positive supraclavicular nodes, or massive atelectasis. - Consent forms:You must be logged in to view the documents.
- Protocols:You must be logged in to view the documents.
A Randomized Phase II Trial of Different Schedules of Topotecan for the Treatment of Extensive-Stage Small Cell Lung Cancer
93-20-53
- Eligibility:Click Here to View
- Consent forms:You must be logged in to view the documents.
- Protocols:You must be logged in to view the documents.
Phase I/II Study of Chemo-Radiotherapy Used Pre-Operatively or Definitively in Carcinoma of the Esophagus or GE Junction
94-474
- Eligibility:Click Here to View1.0) Path (+) squamous cell or adeno CA of esopha/GE junction
2.0) T1-2,Nx-N1,M0.
3.0) PS 0-2.
Drugs: Cisplatinum, 5FU - Consent forms:You must be logged in to view the documents.
- Protocols:You must be logged in to view the documents.
Phase I/II Study of Post-Cryosurgery (Salvage) Radiotherapy in Carcinoma of the Prostate
94-476
- Eligibility:Click Here to View1.0) Residual tumor in prostate, periprostatic tissue following definitive cryosurg.
2.0) PS 0-2
3.0) No prior pelvic RT
Drug: Not applicable - Consent forms:You must be logged in to view the documents.
- Protocols:You must be logged in to view the documents.
Colorectal Adenoma Chemoprevention Trial Using Aspirin: A Phase III Study
94-92-51
- Eligibility:Click Here to View1.0) Path (+) colon or rectal cancer.
2.0) Age >30 and <75.
3.0) No current chemo or RT.
4.0) No NSAID use or contraindications to aspirin use.
5.0) No familial polyposis, active\u0009malignancy or inflammatory bowel dz
6.0)
7.0) No immunosuppressive therapy w/in 6 mo. preceeding study entry.
Drug: Aspirin (provided) - Consent forms:You must be logged in to view the documents.
- Protocols:You must be logged in to view the documents.
Phase III Double-Blind Placebo-Controlled Trial to Assess the Effectiveness of Sucralfate in the Prevention of Treatment-Induced Diarrhea in Patients Receiving Pelvic Radiation Therapy
94-92-52
- Eligibility:Click Here to View
- Consent forms:You must be logged in to view the documents.
- Protocols:You must be logged in to view the documents.
A Phase II Trial of Preoperative Paclitaxel and Carboplatin in Patients with Resectable Non-Small Cell Lung Cancer
95-24-51
- Eligibility:Click Here to View1.0) Path (+) NSCLC, T1-3, N0-1, MO (hilar node =1.5 cm on CT considered N1 dz)
2.0) Mediastinoscopy required to exclude N2 dz. See protocol
3.0) No serious cardiac problems.
4.0)
5.0) No prior chemo or RT.
6.0)
Drug: Carbo, Taxol (provided) - Consent forms:You must be logged in to view the documents.
- Protocols:You must be logged in to view the documents.
A Phase II Trial of Edatrexate in Combination With Vinblastine, Adriamycin, Cisplatin, and Filgrastim (EVAC/G-CSF) in Patients With Advanced Non-Small Cell Lung Cancer
95-24-52
- Eligibility:Click Here to View
- Consent forms:You must be logged in to view the documents.
- Protocols:You must be logged in to view the documents.
Phase III Controlled Evaluation of Glutamine for Decreasing Stomatitis in Patients Receiving 5FU (Fluorouracil) - Based Chemotherapy
95-92-51
- Eligibility:Click Here to View
- Consent forms:You must be logged in to view the documents.
- Protocols:You must be logged in to view the documents.